chr5-58459809-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006622.4(PLK2):c.151G>A(p.Val51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,609,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006622.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLK2 | NM_006622.4 | c.151G>A | p.Val51Met | missense_variant | 1/14 | ENST00000274289.8 | |
PLK2 | NM_001252226.2 | c.151G>A | p.Val51Met | missense_variant | 1/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLK2 | ENST00000274289.8 | c.151G>A | p.Val51Met | missense_variant | 1/14 | 1 | NM_006622.4 | P1 | |
PLK2 | ENST00000617412.1 | c.151G>A | p.Val51Met | missense_variant | 1/15 | 5 | |||
PLK2 | ENST00000504196.1 | n.278G>A | non_coding_transcript_exon_variant | 1/2 | 2 | ||||
PLK2 | ENST00000514306.1 | n.51G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000329 AC: 8AN: 243350Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133138
GnomAD4 exome AF: 0.0000323 AC: 47AN: 1457088Hom.: 0 Cov.: 31 AF XY: 0.0000331 AC XY: 24AN XY: 725194
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.151G>A (p.V51M) alteration is located in exon 1 (coding exon 1) of the PLK2 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the valine (V) at amino acid position 51 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at